Replay available

Genomma Lab Intl Sab Ord (GNMLF) Q4 2024 Earnings Call

Genomma Lab Intl Sab Ord (OTC: GNMLF) Q4 2024 earnings conference call, held 2025-02-27. Replay captured from the company's public earnings webcast.

Thu, February 27, 2025 at 12:00 PMendedReplay
Genomma Lab Intl Sab Ord (GNMLF) Q4 2024 Earnings Call

Hosted by

Featured presenters

Christian Ibanez

Head of Investor Relations

Marcos Barbieri

Chief Executive Officer

Antonio Zamora

Chief Financial Officer

Antonio Hernandez

Analyst, Actinver

Alvaro Garcia

Analyst, BTG Paxful

James McDermottro

Analyst, Invesco

Miguel Ulloa

Analyst, BBVA

Unknown Participant

Participant

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genomma Lab Internacional Sab De Cv Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.919 Greetings, ladies and gentlemen. Thank you for joining Genoma Labs' fourth quarter 2024 00:00:05.919 -- 00:00:08.402 earnings conference call. 00:00:08.402 -- 00:00:11.826 All participants will be in listen-only mode. 00:00:11.826 -- 00:00:16.473 After today's presentation, there will be an opportunity to ask questions. 00:00:16.473 -- 00:00:21.659 As a reminder, this meeting is being recorded and will be available for replay 00:00:21.659 -- 00:00:25.985 on the Investor Relations section of Genoma's website following the call. 00:00:25.985 -- 00:00:31.291 I'll now turn the call over to Christian Ibanez, Genoma's Head of Investor 00:00:31.291 -- 00:00:34.793 Relations. Please, go ahead. 00:00:34.793 -- 00:00:39.960 Thank you, and welcome, everyone. On today's call are Marcos Barbieri, Chief Executive 00:00:39.960 -- 00:00:43.765 Officer, and Antonio Zamora, Chief Financial Officer. 00:00:43.765 -- 00:00:48.631 Before we get started, I'd like to remind you that the remarks today will include forward-looking 00:00:48.631 -- 00:00:53.738 statements, such as the company's financial guidance and expectations, including 00:00:53.738 -- 00:00:59.145 long-term objectives and forecasts, as well as expectations regarding Genoma's business, 00:00:59.145 -- 00:01:02.890 assets, products, strategies, demands, and markets. 00:01:02.890 -- 00:01:07.356 These statements are subject to risks and uncertainties that could cause actual results 00:01:07.356 -- 00:01:12.524 to differ materially. They are also based on assumptions as of today, and the company 00:01:12.524 -- 00:01:17.571 undertakes no obligation to update them as a result of new information or 00:01:17.571 -- 00:01:20.355 future events. Let me now turn the call over to Mr. 00:01:20.355 --...